Paradigm Asset Management Co. LLC Increases Stock Position in Humana Inc. (NYSE:HUM)

Paradigm Asset Management Co. LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 766.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,600 shares of the insurance provider’s stock after purchasing an additional 2,300 shares during the quarter. Paradigm Asset Management Co. LLC’s holdings in Humana were worth $660,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. AMF Tjanstepension AB raised its holdings in shares of Humana by 166.8% in the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock valued at $12,686,000 after buying an additional 25,041 shares during the last quarter. Sequoia Financial Advisors LLC increased its position in Humana by 3.2% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,408 shares of the insurance provider’s stock valued at $763,000 after acquiring an additional 74 shares during the period. Eastern Bank purchased a new stake in Humana during the 3rd quarter valued at approximately $90,000. Lecap Asset Management Ltd. acquired a new stake in Humana during the 3rd quarter worth approximately $520,000. Finally, IFM Investors Pty Ltd grew its stake in shares of Humana by 0.5% in the 3rd quarter. IFM Investors Pty Ltd now owns 25,370 shares of the insurance provider’s stock valued at $8,036,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on HUM. Wells Fargo & Company dropped their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Finally, TD Cowen increased their price objective on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $285.68.

Humana Stock Performance

NYSE:HUM opened at $255.77 on Friday. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The firm has a 50 day simple moving average of $269.41 and a 200-day simple moving average of $290.45. The firm has a market cap of $30.80 billion, a PE ratio of 25.71, a P/E/G ratio of 2.00 and a beta of 0.56. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.